论文部分内容阅读
目的:探讨妈富隆治疗围绝经期功能失调性子宫出血的临床疗效。方法:选取2011年~2013年在我院进行围绝经期治疗的患者100例,随机将其分为对照组和观察组各50例,对照组采用诊断性刮宫术进行治疗,观察组在诊刮术后采用妈富隆进行治疗,1个周期3周,持续治疗3个周期。结果:观察组的治疗总有效率(93.7%)明显高于对照组(50.6%),有统计学意义(P<0.05);治疗后2组的血红蛋白(Hb)水平都明显提高,但观察组水平明显高于对照组(P<0.05);2组患者治疗3周期后及流血不规则发生率小于月经量比较(P<0.05),停药后的复发率没有统计学差异(P>0.05);2组均无明显的不良反应(P>0.05)。结论:采用妈富隆治疗围绝经期功血有良好的疗效,具有很好的临床价值。
Objective: To investigate the clinical efficacy of Marvelon in treating peri-menopausal dysfunctional uterine bleeding. Methods: A total of 100 patients who underwent perimenopausal period in our hospital from 2011 to 2013 were randomly divided into control group and observation group, 50 cases in each group. The control group was treated by diagnostic curettage, while the observation group was treated by curettage After treatment with Marvelon treatment, 1 cycle of 3 weeks, continuous treatment of 3 cycles. Results: The total effective rate (93.7%) in the observation group was significantly higher than that in the control group (50.6%) (P <0.05). The hemoglobin (Hb) levels in the two groups were significantly increased after treatment (P <0.05). After 3 cycles of treatment and the incidence of irregular bleeding was less than that of menstrual flow in the two groups (P <0.05), the recurrence rate after stopping treatment was not significantly different (P> 0.05) There was no significant adverse reaction in both groups (P> 0.05). Conclusion: The use of Marvelon treatment of perimenopausal dysfunctional uterine bleeding has a good effect, with good clinical value.